IP Library Assignment 052998/0013
Patent Assignment
Reel/Frame 052998/0013

Assignment of Assignor's Interest

Recorded: 2020-06-22 Pages: 3
Assignor
ERLANSON, DANIEL
Executed: 2011-01-04
Assignee
SUNESIS PHARMACEUTICALS, INC.
395 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Property (1)
Heterocyclic Compounds Useful as PDK1 Inhibitors
Application: 16/904,890 →
Publication: US 2021/0070752
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 22, 2020
From: BIOGEN IDEC MA INC.
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 052998/0021 →
Assignment of Assignor's Interest Jun 22, 2020
From: ARNDT, JOSEPH; CHAN, TIMOTHY; GUCKIAN, KEVIN; KUMARAVEL, GNANASAMBANDAM
To: BIOGEN IDEC MA INC.
Reel/Frame 053568/0515 →
Change of Name Dec 9, 2021
From: SUNESIS PHARMACEUTICALS, INC.
To: VIRACTA THERAPEUTICS, INC.
Reel/Frame 058741/0187 →